ResMed (RMD) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $223.35 -0.12%
Revenue Growth %: +6.9%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.9%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.49, $0.04 better than the analyst estimate of $1.45. Revenue for the quarter came in at $914.7 million versus the consensus estimate of $910.54 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Ennis (EBF) Misses Q2 EPS by 2c
- Exelon (EXC) PT Lowered to $49 at Argus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
